Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: life extension – Page 535

Announcing the “Ending Age-Related Diseases” Conference

The first conference on ageing research organised by the Life Extension Advocacy Foundation is coming to New York on July 12th!

We’re extremely excited to announce “Ending Age-Related Diseases: Investment Prospects & Advances in Research”, the very first rejuvenation biotechnology conference that LEAF has organized.

Respected speakers from around the globe

The event, which will take place on July 12, 2018 from 10:30 AM to 6:00 PM EDT in New York City, is one of the many LEAF initiatives made possible by the support of our Heroes; it will feature a superb series of speakers—researchers, investors, advocates—including gerontologist and stem cell pioneer Dr. Michael West from AgeX Therapeutics; Bioage Labs Vice President and regenerative medicine specialist Dr. Alexandra Stolzing; SENS Research Foundation CSO Dr. Aubrey de Grey, pioneer of the maintenance approach to aging; “Fight Aging!” blog editor and co-founder of the recently launched Repair Biotechnologies; and, of course, LEAF President Keith Comito and LEAF Vice President Dr. Oliver Medvedik.

Scientists Kick Off Synthetic Biology Project to Make Virus-Resistant Super Cells

Recently, roughly 200 eminent scientists assembled in Boston. Their agenda? Creating “superhero” human cells impervious to all viral attacks and possibly other killers—radiation, freezing, aging, or even cancer.

The trick isn’t super-soldier serum. Instead, the team is relying on tools from synthetic biology to read the cell’s genetic blueprint and rewrite large chunks of the genome to unlock these superpowers.

“There is very strong reason to believe that we can produce cells that would be completely resistant to all known viruses,” said Dr. Jef Boeke, a geneticist at New York University and a co-leader of the project. “It should also be possible to engineer other traits, including resistance to prions and cancer.”

Reviewing Genomic Instability, Cellular Senescence, and Aging

Today, we wanted to bring your attention to a new review that takes an in-depth look at genomic instability, senescent cell accumulation, and its role in aging.

DNA damage as a driver of aging

Genomic instability, otherwise known as DNA damage, is thought by many researchers to be a primary reason why we age. Damage to, and imperfect repair of, the genomes of stem and progenitor cells causes mutations, which are then passed to the somatic cells they create [1].

‘Westworld’ and the Question of Immortality

Westworld’s first season was largely focused on the abuse of artificial life, given that the park hosts’ purpose almost exclusively revolved around sex, violence, and suffering. The freedom Dolores and her ilk were fighting for was simple consciousness—a right to their own memories and self-awareness. In just the first four episodes, Westworld’s second season has exploded that basic quest into all kinds of fascinating directions, but “The Riddle of the Sphinx” was the first to really grapple with one of the most obvious questions in AI, which is: Isn’t artificial intelligence the key to immortality?

Three Atlantic staffers discuss “The Riddle of the Sphinx,” the fourth episode of Season 2.

The Astana Global Challenges Summit 2018

The Astana Global Challenge Summit 2018 will host a series of panels and talks on longevity and rejuvenation.

As it has every year since 2008, the Astana Economic Forum (AEF) is about to take place in Astana, Kazakhstan. AEF, now also known as the Global Challenges Summit (GCS), is an international and regional non-profit platform for public discourse on topics such as economics, globalization, security, global risks, energy efficiency, innovation, and, more generally, matters concerning the future of our world and society. It was jointly created by the Eurasian Economic Club of Scientists Association and the Kazakhstan government back in 2008, and over the years, it has hosted innumerable talks and presentations by scientists, economists, world leaders, entrepreneurs, Nobel laureates, and other key people.

In our rapidly changing world, where we sometimes struggle to keep up the pace with progress, initiatives like this are greatly needed and welcome. In order to address the global issues we will face in the coming decades, cooperation, dialogue, information sharing, and networking will be pivotal, and events like the GCS are instrumental in achieving success. The themes of the 2018 event, which will be held on May 17–19, will include global strategy, sustainability, the future of money, clean energy, a unified economy, and many others. Around 500 speakers from all over the world will be on stage to discuss these important topics, sharing visions and insights to build a brighter and safer future together.

Reason – Fight Aging! blog and Repair Biotechnologies

An interview on rejuvenation science, advocacy, and more with Reason from the blog Fight Aging!.

Most people interested in rejuvenation and life extension are familiar with Fight Aging!, one of the very first rejuvenation advocacy blogs dating back all the way to the early 2000s; if you’re one of them, then you certainly are familiar with Reason, the man behind FA!.

Over the years, Reason has been a patient yet relentless advocate, acting not only as an information provider for the public but also helping out innumerable organizations and companies in the field of rejuvenation biotechnology in financial and other ways. Back in the day when SRF didn’t exist yet, Reason was a volunteer for Methuselah Foundation; eventually, he helped fund companies such as Oisìn Biotechnologies, CellAge, and LysoCLEAR; and, earlier this month, Reason and Bill Cherman co-founded Repair Biotechnologies, a company focused on gene therapy for rejuvenation, as announced on FA!.

Bill Cherman is an investor in the rejuvenation community who, just like Reason, has contributed to development of many ventures in the field. He is a holder of a gold medal in the Brazilian Mathematics Olympiad, a BA in economics, and a candidate in the Master of Biotechnology Enterprise and Entrepreneurship program at Johns Hopkins. He founded Front Seat Capital, a venture capital firm looking to invest in startups with the potential to change the world.

Anti-aging protein alpha Klotho’s molecular structure revealed

DALLAS – March 29, 2018 – Researchers from UT Southwestern’s Charles and Jane Pak Center for Mineral Metabolism and Clinical Research and Internal Medicine’s Division of Nephrology recently published work in Nature that reveals the molecular structure of the so-called “anti-aging” protein alpha Klotho (a-Klotho) and how it transmits a hormonal signal that controls a variety of biologic processes. The investigation was performed in collaboration with scientists from New York University School of Medicine and Wenzhou Medical University in China.

Studies at UTSW two decades ago by Dr. Makoto Kuro-o, Professor of Pathology, demonstrated that mice lacking either a-Klotho or the hormone FGF23 suffered from premature and multiple organ failure as well as other conditions, including early onset cardiovascular disease, cancer, and cognitive decline. Because defects in a-Klotho lead to symptoms seen in aging, researchers inferred that a-Klotho suppresses aging, leading to great interest in how the a-Klotho protein might work together with the hormone FGF23 to fulfill their roles.

A-Klotho can exist on the surface of a cell or can be released from the cell and circulate in body fluids, including the blood, as soluble a-Klotho. The cell-attached form and the circulating form of a-Klotho were previously and universally believed to serve completely different functions.

Scientists discover promising off-switch for inflammation

And inflammation is one of the three primary ageing processes.

Scientists have discovered a new metabolic process in the body that can switch off inflammation. They have discovered that ‘itaconate’—a molecule derived from glucose—acts as a powerful off-switch for macrophages, which are the cells in the immune system that lie at the heart of many inflammatory diseases including arthritis, inflammatory bowel disease and heart disease.

The scientists, working in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute at Trinity College Dublin, hope their discovery will have relevance for inflammatory and infectious diseases—and that their findings may also help to develop much-needed new drugs to treat people living with these conditions.

Professor of Biochemistry at Trinity, Luke O’Neill, was, along with Dr. Mike Murphy of the University of Cambridge, the joint leader of the work just published in leading international journal Nature. The discoveries were made using both human cells and mice as a model organism.